cbdMD, Inc. produces and distributes various cannibidiol (CBD) products in the United States. It operates through three segments: Products, Licensing, and Entertainment. The Products segment produces and markets CBD tinctures, capsules, gummies, bath bombs, vape oils, topical creams, and animal treats and oils under the cdbMD brand. The Licensing segment establishes brands through licensing of select products/categories focusing on health and wellness, and men's lifestyle products. The Entertainment segment produces and markets various entertainment distribution platforms under the EE1 brand. This segment offers recordings, film, TV, Web and live events, and entertainment experiences; and brand management services, including creative development and marketing, brand strategy, and distribution support. cbdMD, Inc. also provides hair care products, including shampoos, conditioners, styling aides, and a patented styling tool through retailers and online outlets. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was founded in 2015 and is based in Charlotte, North Carolina.
Industry, Sector and Symbol
Industry Marketing Services
Sub-IndustryN/A
SectorConsumer Cyclical
CIKN/A
Phone704-445-5800
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees50
Next Earnings Date12/12/2019 (Estimated)
OptionableNot Optionable
cbdMD (NYSEAMERICAN:YCBD) Frequently Asked Questions
What is cbdMD's stock symbol?
cbdMD trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "YCBD."
How were cbdMD's earnings last quarter?
cbdMD, Inc. (NYSEAMERICAN:YCBD) announced its quarterly earnings results on Wednesday, August, 14th. The company reported ($0.24) earnings per share (EPS) for the quarter. The business had revenue of $9.78 million for the quarter. View cbdMD's Earnings History.
When is cbdMD's next earnings date?
What guidance has cbdMD issued on next quarter's earnings?
cbdMD updated its FY 2020 earnings guidance on Wednesday, August, 14th. The company provided EPS guidance of for the period. The company issued revenue guidance of $80-90 million, compared to the consensus revenue estimate of $60 million.
Has cbdMD been receiving favorable news coverage?
Media headlines about YCBD stock have been trending positive on Sunday, according to InfoTrie Sentiment. The research group rates the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. cbdMD earned a media sentiment score of 2.5 on InfoTrie's scale. They also gave news stories about the company a news buzz of 6.0 out of 10, meaning that recent news coverage is somewhat likely to have an impact on the stock's share price in the next several days. View News Stories for cbdMD.
Who are some of cbdMD's key competitors?
Some companies that are related to cbdMD include IVE Group (IGL), QMS Media (QMS), Wellcom Group (WLL), Tremor International (TRMR), GTN (GTN), Taptica International (TAP), Cello Health (CLL), Salmat (SLM), Trimantium Growthops (TGO), NAHL Group (NAH), I Synergy Group (IS3), Arena Events Group (ARE), Ebiquity (EBQ), System1 Group (SYS1) and Tech Mpire (TMP).
What other stocks do shareholders of cbdMD own?
How do I buy shares of cbdMD?
Shares of YCBD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is cbdMD's stock price today?
One share of YCBD stock can currently be purchased for approximately $4.03.
How big of a company is cbdMD?
What is cbdMD's official website?
How can I contact cbdMD?
The company can be reached via phone at 704-445-5800.
MarketBeat Community Rating for cbdMD (NYSEAMERICAN YCBD)
MarketBeat's community ratings are surveys of what our community members think about cbdMD and other stocks. Vote "Outperform" if you believe YCBD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe YCBD will underperform the S&P 500 over the long term. You may vote once every thirty days.
